Insys Founder Says 4th Circ. Ruling Aids New Trial Bid

Law360 (June 26, 2020, 6:00 PM EDT) -- Convicted Insys Therapeutics Inc. founder John Kapoor told the First Circuit Thursday that the new trial ordered by the Fourth Circuit for a West Virginia doctor in an opioid case supports his own appeal because the jury may have been swayed by dramatic, but irrelevant, patient testimony.

Kapoor alerted the appellate panel to the Fourth Circuit's June 19 reversal of the conviction of Felix Brizuela Jr. In that case, four of Brizuela's patients took the stand and described the horrors of opioid addiction, even though Brizuela hadn't been charged with writing bad prescriptions for those patients.

"These patients vividly described becoming addicted...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!